About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of transforming treatment approaches for central nervous system (CNS) disorders. Our commitment to innovation drives us to identify crucial gaps in care and develop distinct therapies based on novel mechanisms of action, leading to significant improvements in patient outcomes. Our cutting-edge neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, and migraines, alongside multiple late-stage development programs targeting a wide array of serious neurological and psychiatric conditions affecting over 150 million individuals across the United States. We are united in our mission to tackle some of the most pressing challenges facing brain health, enabling patients and their families to thrive.

